Tharimmune, Inc. — Director's Dealing 2025

Jul 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-06-23

Reporting Person: Anderson Kelly (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-23	Common Stock	A	6300	—	Acquired	6300	Direct

Footnotes

F1: Common stock issued pursuant to the Tharimmune, Inc. 2023 Omnibus Equity Incentive Plan.